Cell‐penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival-Reference-Cited by-同舟云学术

Cell‐penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival

Published:2019-06-06 Issue:10 Volume:120 Page:18077-18087
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Tabtimmai Lueacha¹,Suphakun Praphasri¹,Srisook Pimonwan¹,Kiriwan Duangnapa²,Phanthong Siratcha³,Kiatwuthinon Pichamon¹,Chaicumpa Wanpen³,Choowongkomon Kiattawee¹

Affiliation:

1. Department of Biochemistry, Faculty of Science Kasetsart University Bangkok Thailand

2. Genetic Engineering Interdisciplinary Program, Graduate School Kasetsart University Bangkok Thailand

3. Department of Parasitology, Faculty of Medicine Siriraj Hospital, Center of Research Excellence on Therapeutic Proteins and Antibody Engineering Mahidol University Bangkok Thailand

Funder

Thailand Research Fund

National Science and Technology Development Agency

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.29111

Reference40 articles.

1. The EGFR as a target for anticancer therapy—focus on cetuximab

2. Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains